Log In
Print this Print this

OncoTrac (Mint Lesion)

  Manage Alerts
Collapse Summary General Information
Company Mint Medical GmbH
DescriptionImaging software to quantitatively assess the treatment response of metastatic tumors using acceptable standards, such as RECIST and WHO
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsCancer, Diagnostic
Regulatory Designation
PartnerTranslational Sciences Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today